EU Law of Competition and Trade in the Pharmaceutical Sector

preview-18
  • EU Law of Competition and Trade in the Pharmaceutical Sector Book Detail

  • Author : Pablo Figueroa
  • Release Date : 2019
  • Publisher : Edward Elgar Publishing
  • Genre : Business & Economics
  • Pages : 758
  • ISBN 13 : 1785362615
  • File Size : 2,2 MB

EU Law of Competition and Trade in the Pharmaceutical Sector by Pablo Figueroa PDF Summary

Book Description: This book provides a systematic analysis of the law and practice of EU competition and trade in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-level officials at competition regulators, this work provides valuable insider knowledge on the application of law and policies to the pharmaceutical industry. The work contains extensive commentary on the legislation and the latest case law and administrative precedents in this sector, at both EU and national level, including certain significant jurisdictions (e.g., the US, China). Coverage of various key developments includes the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturers. In addition to the legal analysis, it offers vital economic and business perspectives to ensure that the reader has the full range of tools with which to prepare for cases and conduct transactions within the pharmaceutical industry.

Disclaimer: www.yourbookbest.com does not own EU Law of Competition and Trade in the Pharmaceutical Sector books pdf, neither created or scanned. We just provide the link that is already available on the internet, public domain and in Google Drive. If any way it violates the law or has any issues, then kindly mail us via contact us page to request the removal of the link.

EU Competition Law and Pharmaceuticals

EU Competition Law and Pharmaceuticals

File Size : 2,2 MB
Total View : 866 Views
DOWNLOAD

This timely book discusses the application of the EU competition rules to pharmaceuticals, covering the prohibitions on anticompetitive agreements and abuse of